den Brok W - Search Results

1

Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment.

Zaikova E, Cheng BYC, Cerda V, Kong E, Lai D, Lum A, Bates C, den Brok W, Kono T, Bourque S, Chan A, Feng X, Fenton D, Gurjal A, Levasseur N, Lohrisch C, Roberts S, Shenkier T, Simmons C, Taylor S, Villa D, Miller R, Aguirre-Hernandez R, Aparicio S, Gelmon K. Zaikova E, et al. Among authors: den brok w. NPJ Breast Cancer. 2024 Jan 5;10(1):3. doi: 10.1038/s41523-023-00607-1. NPJ Breast Cancer. 2024. PMID: 38182588 Free PMC article.

2

Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma.

Villa D, Sehn LH, Savage KJ, Toze CL, Song K, den Brok WD, Freeman CL, Scott DW, Gerrie AS. Villa D, et al. Among authors: den brok wd. Blood Adv. 2020 Aug 11;4(15):3486-3494. doi: 10.1182/bloodadvances.2020002068. Blood Adv. 2020. PMID: 32735654 Free PMC article.

3

Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.

Zhao EY, Shen Y, Pleasance E, Kasaian K, Leelakumari S, Jones M, Bose P, Ch'ng C, Reisle C, Eirew P, Corbett R, Mungall KL, Thiessen N, Ma Y, Schein JE, Mungall AJ, Zhao Y, Moore RA, Den Brok W, Wilson S, Villa D, Shenkier T, Lohrisch C, Chia S, Yip S, Gelmon K, Lim H, Renouf D, Sun S, Schrader KA, Young S, Bosdet I, Karsan A, Laskin J, Marra MA, Jones SJM. Zhao EY, et al. Among authors: den brok w. Clin Cancer Res. 2017 Dec 15;23(24):7521-7530. doi: 10.1158/1078-0432.CCR-17-1941. Clin Cancer Res. 2017. PMID: 29246904

4

Homologous Recombination Deficiency in Breast Cancer: A Clinical Review.

den Brok WD, Schrader KA, Sun S, Tinker AV, Zhao EY, Aparicio S, Gelmon KA. den Brok WD, et al. JCO Precis Oncol. 2017 Nov;1:1-13. doi: 10.1200/PO.16.00031. JCO Precis Oncol. 2017. PMID: 35172494 Review.

5

Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?".

den Brok WD, Speers CH, Gondara L, Baxter E, Tyldesley SK, Lohrisch CA. den Brok WD, et al. Breast Cancer Res Treat. 2017 Apr;162(2):397-398. doi: 10.1007/s10549-017-4114-y. Breast Cancer Res Treat. 2017. PMID: 28110478 No abstract available.

6

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.

den Brok WD, Speers CH, Gondara L, Baxter E, Tyldesley SK, Lohrisch CA. den Brok WD, et al. Breast Cancer Res Treat. 2017 Feb;161(3):549-556. doi: 10.1007/s10549-016-4080-9. Epub 2016 Dec 20. Breast Cancer Res Treat. 2017. PMID: 28000014

7

The long and winding road.

DenBrok W, Simmons C, Gelmon KA. DenBrok W, et al. J Clin Oncol. 2015 Jan 20;33(3):229-31. doi: 10.1200/JCO.2014.59.2311. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452438 Free article. No abstract available.

8

Self-controlled technologies to support skill attainment in persons with an autism spectrum disorder and/or an intellectual disability: a systematic literature review.

den Brok WL, Sterkenburg PS. den Brok WL, et al. Disabil Rehabil Assist Technol. 2015 Jan;10(1):1-10. doi: 10.3109/17483107.2014.921248. Epub 2014 May 22. Disabil Rehabil Assist Technol. 2015. PMID: 24848443 Review.

9

Are two heads better than one? Comparing dyad and self-regulated learning in simulation training.

Shanks D, Brydges R, den Brok W, Nair P, Hatala R. Shanks D, et al. Among authors: den brok w. Med Educ. 2013 Dec;47(12):1215-22. doi: 10.1111/medu.12284. Med Educ. 2013. PMID: 24206155 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page